Loading...
Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1
Aberrant activation of the mammalian target of rapamycin (mTOR) pathway occurs in polycystic kidney disease (PKD). mTOR inhibitors, such as rapamycin, are highly effective in several rodent models of PKD, but these models result from mutations in genes other than Pkd1 and Pkd2, which are the primary...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2831854/ https://ncbi.nlm.nih.gov/pubmed/20075061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009040421 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|